Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Health, Inc. (HIMS) Reports Q3 Loss, Tops Revenue Estimates
06:47pm, Monday, 06'th Nov 2023
Hims & Hers Health, Inc. (HIMS) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.09 per share a year ago.
Hims and Hers narrows loss, raises revenue guidance for the year
04:22pm, Monday, 06'th Nov 2023
Shares of Hims & Hers Health Inc. HIMS, -3.09% rose more than 3% in the extended session Monday after the telehealth company narrowed its quarterly loss and raised its sales guidance for the year, say
Hims & Hers: A Promising Company With Resolvable Challenges
03:44am, Thursday, 02'nd Nov 2023
While HIMS showcases robust performance, its ability to navigate and mitigate associated risks will be pivotal in securing its future success. Major risks revolve around customer service issues, risin
Hims & Hers: Specialization Is The Secret To Great Growth
10:44pm, Tuesday, 24'th Oct 2023
Hims & Hers Health offers personalized and customized telehealth services, specializing in niche treatments for hair loss, erectile dysfunction, skincare, acne, and mental health. The company has expe
Where Will Hims & Hers Health Be in 5 Years?
10:15am, Thursday, 19'th Oct 2023
Hims & Hers continued to grow at an impressive rate of more than 80% last quarter. The telehealth company has been expanding into more areas of healthcare.
Is Hims & Hers Health Stock a Buy Now?
05:35am, Tuesday, 03'rd Oct 2023
Hims & Hers is cutting prices, but profit margins are rising. The company is cash flow positive, with plenty of cash on the balance sheet.
Rocket Stocks: 3 Investments Primed to Skyrocket by Year's End
06:01am, Wednesday, 27'th Sep 2023
Some companies stand out as genuine contenders for explosive growth and substantial gains in the stock market. The article lists three stocks to buy now that have thrived thanks to their innovative st
2 Beaten-Down Growth Stocks That Could Rocket 107% to 127% Higher, According to Wall Street
07:07am, Tuesday, 26'th Sep 2023
Consensus price targets from Wall Street analysts suggest a pair of healthcare stocks can more than double your money. Hims & Hers Health runs an increasingly popular niche telehealth platform where p
Hims and Hers Stock Analysis: Buy or Sell?
06:00am, Friday, 22'nd Sep 2023
The healthcare company is demonstrating excellent revenue growth.
Hims & Hers Health: Risks Remain, But Upgrading To Buy
11:55pm, Wednesday, 20'th Sep 2023
Hims & Hers reported strong earnings and raised its full-year guidance, but its stock continues to decline. Hims & Hers is focusing on personalization and expanding into new categories to drive growth
Hims & Hers: Myopic Shorts, Absurdly Cheap
10:46am, Wednesday, 20'th Sep 2023
Hims & Hers Health, Inc. is rapidly growing and becoming more profitable, making it a cheaply valued stock with minimal risk. A recent short report questions Hims' ability to turn customer acquisition
2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
08:00am, Tuesday, 19'th Sep 2023
Beauty stocks have not been pretty this year. Cosmetics retailer Ulta Beauty Inc. NASDAQ: ULTA and Estee Lauder Co. NYSE: EL shares are trading down 12.3% and 38.7%, respectively.
The Market Is Wrong On Hims & Hers Health
11:00pm, Sunday, 17'th Sep 2023
Hims & Hers managed to grow revenue every year by at least 80%. However, it's still trading below its initial price when became publicly traded via SPAC. The company is targeting lofty growth targets
Is This Underrated SPAC Deal Stock a No-Brainer Buy?
05:30am, Wednesday, 06'th Sep 2023
Hims & Hers Health went public through a SPAC merger a couple of years ago. Since then, the stock is down 60%.
This Fast-Growing Company Is the Latest to Launch a Weight-Loss Business
10:54am, Wednesday, 23'rd Aug 2023
The market for weight management could be worth close to $300 billion by the end of the decade. Hims & Hers is planning to launch a weight-loss business by January.
